Cancer BiologybioRxivPreprint
Immunotherapy for ovarian cancer is improved by tumor targeted delivery of a neoantigen surrogate
L. R. Scanlon, L. Gabor, O. R. Khouri…·C. Gravekamp
This study shows that delivering a neoantigen surrogate via Listeria monocytogenes combined with gemcitabine and anti-PD1 improves ovarian cancer treatment in mice.
DOI 10.1101/2023.10.11.561944